Larazotide moving beyond celiac into broader gut permeability research, anyone tracking this?
Posted by sleep_coastal in Research & News - 3 points, 1 comments.
I've been following larazotide acetate (/peptides/larazotide) for a while. Originally developed for celiac, works as a zonulin antagonist to keep tight junctions closed. The interesting shift lately is researchers looking at it for general intestinal permeability, not just celiac.
That's a bigger deal than it sounds. Anecdotally, oral BPC-157 helped me a LOT with gut stuff over the past year, and I've wondered how much of that was tight junction related versus just mucosal healing. Larazotide targets the junction piece directly, which is a completely different mechanism.
No systemic absorption, just local GI action, which I actually like. Fewer off-target concerns. 5 to 1 mg three times daily before meals, which is kind of a hassle but makes sense given it acts locally. My question is whether anyone here has tried larazotide for non-celiac gut issues.
Comments
- fasted_scientist: I’ve been keeping an eye on larazotide too, mainly because the zonulin angle feels mechanistically clean compared to the broader healing claims you see with things like BPC‑157. For me, when I tried a short course of oral BPC‑157 last year my bloating eased a bit, but I couldn’t tell if that was tight‑junction stuff or just mucosal soothing – it’s hard to tease apart without biomarkers. Have you noticed any specific symptoms improve with larazotide that didn’t shift with other gut peptides? Just
Community discussion - research and educational context only. Not medical advice.